These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7474421)

  • 1. [Allogenic bone marrow transplantation].
    Yamane T; Im T; Nakao T; Kumura T; Tatsumi N
    Rinsho Byori; 1995 Jul; Suppl 99():15-23. PubMed ID: 7474421
    [No Abstract]   [Full Text] [Related]  

  • 2. [Allogeneic bone marrow transplantation of unrelated donors; fewer complication, more donors].
    Liem GS; Cornelissen JJ; Oudshoorn M; Sintnicolaas K; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1997 Aug; 141(32):1553-6. PubMed ID: 9543748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution.
    Rizzieri DA; Koh LP; Long GD; Gasparetto C; Sullivan KM; Horwitz M; Chute J; Smith C; Gong JZ; Lagoo A; Niedzwiecki D; Dowell JM; Waters-Pick B; Liu C; Marshall D; Vredenburgh JJ; Gockerman J; Decastro C; Moore J; Chao NJ
    J Clin Oncol; 2007 Feb; 25(6):690-7. PubMed ID: 17228020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in chronic GvHD and autoimmune diseases.
    Andolina M; Maximova N; Rabusin M; Parco S; Colovic M; Jankovic G
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():145-7. PubMed ID: 8932817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric bone marrow transplantation.
    Chan KW
    Pediatr Dent; 1995; 17(4):291-3. PubMed ID: 7567633
    [No Abstract]   [Full Text] [Related]  

  • 9. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
    Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tissue typing before bone marrow transplantation].
    Kosinski S
    Postepy Hig Med Dosw; 1979; 33(3):221-38. PubMed ID: 42045
    [No Abstract]   [Full Text] [Related]  

  • 11. BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment.
    Ladenstein R; Peters C; Matthes-Martin S; Rosenmayr A; Höcker P; Pötter R; Pötschinger U; Gadner H
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():86-91. PubMed ID: 8932806
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
    Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
    Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper T-lymphocyte precursor frequency predicts the occurrence of graft-versus-host disease and disease relapse after allogeneic bone marrow transplantation from HLA-identical siblings.
    Leung AY; Kwok J; Lie AK; Chen P; Chen FE; Liang R
    Haematologica; 2001 Jun; 86(6):652-6. PubMed ID: 11418376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of chronic graft-versus-host disease after unrelated-donor bone marrow transplantation. Kanazawa University Bone Marrow Transplant Team].
    Takami A; Nakao S; Ueda M; Takamatsu H; Sugimori N; Yamazaki H; Miura H; Ito K; Yamaguchi M; Niki T
    Rinsho Ketsueki; 1995 Jan; 36(1):6-11. PubMed ID: 7715080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
    Davies SM; Weisdorf DJ; Haake RJ; Kersey JH; McGlave PB; Ramsay NK; Blazar BR
    Bone Marrow Transplant; 1994 Jul; 14(1):73-7. PubMed ID: 7951123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplants come of age. New hope for deadly diseases.
    Meadows M
    FDA Consum; 2000; 34(4):22-7. PubMed ID: 11924631
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia.
    Byrne JL; Stainer C; Cull G; Haynes AP; Bessell EM; Hale G; Waldmann H; Russell NH
    Bone Marrow Transplant; 2000 Feb; 25(4):411-7. PubMed ID: 10723585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
    Przepiorka D; Huh YO; Khouri I; Reading C; Hester J; Marshall M; Champlin RE
    Prog Clin Biol Res; 1994; 389():557-63. PubMed ID: 7700921
    [No Abstract]   [Full Text] [Related]  

  • 20. Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease.
    Russell-Jones R
    Bone Marrow Transplant; 1998 Oct; 22(7):621-3. PubMed ID: 9818687
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.